NCT03768245

Brief Summary

Mexico occupies the first place worldwide in childhood obesity. Its urban and indigenous communities present different levels of westernization which have triggered different epidemiological diseases. This study aims to treat and prevent obesity and related diseases. A school-based multi-component intervention program is developed in three ethnic groups with varying levels of westernization: Mestizos, Seris and Yaquis. Measurements are obtained to evaluate obesity, cardiovascular, diabetes risk, hepatic and renal function, and physical fitness. The intervention consists on Physical Activity (PA), Health Education (HE) and Nutrition (NP) programs carried out in six urban (Mestizo ethnic group) and indigenous schools (Seri and Yaqui ethnic groups). A total of 800 participants were part of the PA and HE programs (Education Arm), and 117 of them were also part of the NP program (Nutrition Arm). Measurement differences, after and before treatments are used to assess the intervention effect by age, sex, ethnicity, nutritional status, and treatments. Expanded access is not applicable to this study. The Government's Secretary of Education does not allow developing a plan to share individual data of participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Jul 2016

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2016

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 4, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 7, 2018

Completed
Last Updated

December 7, 2018

Status Verified

December 1, 2018

Enrollment Period

3 months

First QC Date

December 4, 2018

Last Update Submit

December 5, 2018

Conditions

Keywords

Body Mass IndexGlucoseHaemoglobin glycosylatedBlood LipidsLiver FunctionKidney FunctionExercisePhysical activity

Outcome Measures

Primary Outcomes (18)

  • Mean Change From Baseline In Body Mass Index At 12 Weeks

    Weight is measured kilograms using a Seca scale. Height is measured in meters cm using a standardized portable stadiometer Microtoise. Weight and height are be combined to report Body mass index (BMI) in kg/m\^2. BMI cut-off points of normal weight, overweight and obesity are used as defined by World Health Organization5.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Glucose Profile At 12 Weeks

    Blood samples are taken in the morning, after a 10-hours fasting to measure glucose in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Glycated Haemoglobin At 12 Weeks

    Blood samples are taken in the morning, after a 10-hours fasting to glycated haemoglobin in percentage.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Triglycerides At 12 Weeks

    Blood samples are taken in the morning, after a 10-hours fasting to triglycerides in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Total Cholesterol At 12 Weeks

    Blood samples are taken in the morning, after a 10-hours fasting to total cholesterol in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting High Density Lipoprotein Cholesterol At 12 Weeks

    Blood samples are taken in the morning, after a 10-hours fasting to high density lipoprotein cholesterol in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Low Density Lipoproteins Cholesterol At 12 Weeks

    Blood samples are taken in the morning, after a 10-hours fasting to low density lipoprotein cholesterol in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Creatinine At 12 Weeks

    Description Blood samples were taken in the morning, after a 10-hours fasting to measure creatinine in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Urea At 12 Weeks

    Description Blood samples were taken in the morning, after a 10-hours fasting to measure urea in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Urea Nitrogen At 12 Weeks

    Blood samples were taken in the morning, after a 10-hours fasting to measure urea in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Uric Acid At 12 Weeks

    Description Blood samples were taken in the morning, after a 10-hours fasting to measure uric acid in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Glutamic Oxalacetic Transaminase At 12 Weeks.

    Blood samples were taken in the morning, after a 10-hour fast to measure glutamic oxalacetic transaminase measured in international units/litre (U/L).

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Glutamic Pyruvic Transaminase, At 12 Weeks

    Blood samples were taken in the morning, after a 10-hour fast to measure glutamic pyruvic transaminase measured in international units/litre (U/L).

    Up to 12 weeks

  • Mean Change From Baseline In Fasting Bilirubin Profile, At 12 Weeks

    Blood samples were taken in the morning, after a 10-hour fast to measure direct, total and indirect bilirubin, measured in milligrams/decilitres.

    Up to 12 weeks

  • Mean Change From Baseline In Indirect Of Maximum Oxygen Consumption At 12 Weeks

    The Course-Navette test are used to measure the indirect maximum oxygen consumption measured in milligrams/kilograms/minutes.

    Up to 12 weeks

  • Mean Change From Baseline In Speed At 12 Weeks

    Speed is measured in meters/seconds using the 4x10 meters test.

    Up to 12 weeks

  • Mean Change From Baseline In Strength-Resistance At 12 Weeks

    Strength-resistance is measured in number of repetition using the abdominal strength test, which consists of recording the maximum number of abdominals in 30 seconds.

    Up to 12 weeks

  • Mean Change From Baseline In Power At 12 Weeks

    Power is measured in centimetres, using the long jump test which measures the explosive power of the lower body, and the vertical jump test, measured in centimetres, for measuring changes in leg power.

    Up to 12 weeks

Study Arms (2)

Behaviour

EXPERIMENTAL

Physical activity and the Health Education programs are applied.

Behavioral: Health Education and Physical activity program

Nutrition

ACTIVE COMPARATOR

In this Arm, the the Physical activity, the Health education and Nutrition program are applied.

Behavioral: Health Education and Physical activity programDietary Supplement: Nutrition Program

Interventions

Its objective is to empower children on healthy lifestyle, addressing four main topics: nutrition (i.e. healthy food, hydration), adequate quantities of food, physical activity, and self-monitoring. The program is implemented in the classroom through workshops planned and conducted by psychologists and nutritionists. A total of 12 workshops are planned, to be conducted once a week, and lasting 50 minutes each. The Physical activity program objective is to develop an active scholar environment, and consists of a moderate-vigorous activity, five days a week. The activities are divided into two types: (a) in the school backyard for 60 minutes, three times a week, and (b) in the classroom two days a week, for 15 minutes three times a day, adding up to 45 minutes daily.

BehaviourNutrition
Nutrition ProgramDIETARY_SUPPLEMENT

Its objective is to maintain lean mass, decrease fat mass and ensure mineral vitamins and fatty acids intake, maintain proper growth under National Specific Action Program: Food and Activity4. From total energy, a fat intake of 25-35%, carbohydrate intake of 45-65%, protein intake of 10-30%, and total calories are adjusted according to age. The Nutrition program consists of three meals: breakfast, a snack for a mid-morning playtime, and lunch at school. Food is prepared daily following sanitary and quality standards of Mexican official regulation. Breakfast is served 40 minutes before starting class time, lunch is served 40 minutes before leaving school.

Nutrition

Eligibility Criteria

Age4 Years - 13 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children from the selected grades and schools.
  • Children who voluntarily accept participating in the program.
  • Children whose parents must authorize their participation in the program, signing an informed consent document.

You may not qualify if:

  • Participants with any incapacity to perform physical activity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Regional Adolfo Lopez Matelos

Mexico City, Mexico City, 01620, Mexico

Location

Related Publications (1)

  • Costa-Urrutia P, Alvarez-Farina R, Abud C, Franco-Trecu V, Esparza-Romero J, Lopez-Morales CM, Rodriguez-Arellano ME, Valle Leal J, Colistro V, Granados J. Effect of multi-component school-based program on body mass index, cardiovascular and diabetes risks in a multi-ethnic study. BMC Pediatr. 2019 Nov 4;19(1):401. doi: 10.1186/s12887-019-1787-x.

Related Links

MeSH Terms

Conditions

ObesityDiabetes Mellitus, Type 2Kidney DiseasesLiver DiseasesMotor Activity

Interventions

Food Assistance

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesEndocrine System DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesDigestive System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Public AssistanceFinancing, GovernmentFinancing, OrganizedEconomicsHealth Care Economics and Organizations

Study Officials

  • Paula Costa-Urrutia, Ph.D

    Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The intervention program is split into two groups of participants which receive two deferments treatments (Arms); treatment (Arm 1) is applied to all participants (n=800), while treatment 2 (Arm 2) is randomly applied just in the Mestizo group (n=117), i.e. schools and grade are randomly allocated in Arm 2
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D

Study Record Dates

First Submitted

December 4, 2018

First Posted

December 7, 2018

Study Start

July 1, 2016

Primary Completion

September 15, 2016

Study Completion

November 30, 2016

Last Updated

December 7, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations